Total number of projects: 4
As coordinator: 1
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.33*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 11.940.343 | 177.200 | 1 | ||
2012 | 4.880.575 | 2.999.956 | 1.163.612 | 1 | 1 | |
2010 | 0 | 2.399.998 | 50.968 | 1 |
Total number of partners: 283
Partner loyalty:
Frequent Partner: (> 2 projects): 35
Rare Partner: 248
Frequent / Rare Partner Ratio: 0.14
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-01-01 | "Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative" | FRAILOMIC | participant | 11.940.343 | 23 |
2012-11-01 | Best EScalation Treatment in Multiple Sclerosis (MS) | BEST MS | coordinator | 4.880.575 | 5 |
2012-10-01 | Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) | DSD-LIFE | participant | 2.999.956 | 16 |
2010-09-01 | Diagnostic Enhancement of Confidence by an International Distributed Environment | DECIDE | participant | 2.399.998 | 13 |